Danger signals from ATP and adenosine in pregnancy and preeclampsia

Hypertension

Volumn 63, Issue 6, 2014, Pages 1154-1160

  Spaans, Floor ^a   De Vos, Paul ^a   Bakker, Winston W ^a   Van Goor, Harry ^a   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ANGIOTENSIN RECEPTOR; CD39 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; NITRIC OXIDE; PURINERGIC P2 RECEPTOR; VASCULOTROPIN;

BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; THROMBOCYTE ACTIVATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; HUMANS; MODELS, CARDIOVASCULAR; PRE-ECLAMPSIA; PREGNANCY;

EID: 84902239356     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03240     Document Type: Review

References (104)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-137.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
3. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl A):S32-S37.
4. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(Suppl A):S38-S42.
5. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112:358-404.
6. Bakker WW, Donker RB, Timmer A, van Pampus MG, van Son WJ, Aarnoudse JG, van Goor H, Niezen-Koning KE, Navis G, Borghuis T, Jongman RM, Faas MM. Plasma hemopexin activity in pregnancy and preeclampsia. Hypertens Pregnancy. 2007;26:227-239.
7. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem. 2002;277:44638- 44650.
8. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC, Sutterwala FS. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A. 2009;106:20388-20393.
9. Choi J, Hammer LW, Hester RL. Calcium-dependent synthesis of prostacyclin in ATP-stimulated venous endothelial cells. Hypertension. 2002;39(2 Pt 2):581-585.
10. Gödecke S, Roderigo C, Rose CR, Rauch BH, Gödecke A, Schrader J. Thrombin-induced ATP release from human umbilical vein endothelial cells. Am J Physiol Cell Physiol. 2012;302:C915-C923.
11. Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783:673-694.
12. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem. 1996;271:33116-33122.
13. Yoneyama Y, Suzuki S, Sawa R, Kiyokawa Y, Power GG, Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet Gynecol. 2001;97:366-370.
14. Jacob F, Pérez Novo C, Bachert C, Van Crombruggen K. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal. 2013;9:285-306.
15. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.
16. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol. 2001;13:114-119.
17. Bodin P, Burnstock G. Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol. 2001;38:900-908.
18. Lazarowski ER. Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal. 2012;8:359-373.
19. Burnstock G. Discovery of purinergic signalling, the initial resistance and current explosion of interest. Br J Pharmacol. 2012;167:238-255.
20. Bodin P, Burnstock G. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res. 1998;47:351-354.
21. Lader AS, Prat AG, Jackson GR Jr, Chervinsky KL, Lapey A, Kinane TB, Cantiello HF. Increased circulating levels of plasma ATP in cystic fibrosis patients. Clin Physiol. 2000;20:348-353.
22. Mortaz E, Folkerts G, Nijkamp FP, Henricks PA. ATP and the pathogenesis of COPD. Eur J Pharmacol. 2010;638:1-4.
23. Gomez G, Apasov S, Sitkovsky MV. Immunosuppressive effects of extracellular adenosine on immune cells: implications for the pathogenesis of ADA SCID and immunomodulation. Drug Dev Res. 2001;53:218-224.
24. von Versen-Höynck F, Rajakumar A, Bainbridge SA, Gallaher MJ, Roberts JM, Powers RW. Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta. 2009;30:434-442.
25. Roberts VH, Greenwood SL, Elliott AC, Sibley CP, Waters LH. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1374-R1386.
26. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008;4:1-20.
27. Yamamoto K, Sokabe T, Matsumoto T, et al. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med. 2006;12:133-137.
28. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature. 2000;403:86-89.
29. Ji X, Naito Y, Hirokawa G, Weng H, Hiura Y, Takahashi R, Iwai N. P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res. 2012;35:173-179.
30. Palomino-Doza J, Rahman TJ, Avery PJ, Mayosi BM, Farrall M, Watkins H, Edwards CR, Keavney B. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension. 2008;52:980-985.
31. Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension. 2005;46:562-568.
32. Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T. Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am J Physiol Heart Circ Physiol. 2011;301:H1850-H1861.
33. 2+ influx via Ca(v)1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction. Br J Pharmacol. 2012;166:1503-1512.
34. Kawamura H, Sugiyama T, Wu DM, Kobayashi M, Yamanishi S, Katsumura K, Puro DG. ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol. 2003;551(Pt 3):787-799.
35. Hohl CM, Hearse DJ. Vascular and contractile responses to extracellular ATP: studies in the isolated rat heart. Can J Cardiol. 1985;1:207-216.
36. Silva G, Beierwaltes WH, Garvin JL. Extracellular ATP stimulates NO production in rat thick ascending limb. Hypertension. 2006;47:563-567.
37. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28:2049-2055.
38. Seiffert K, Ding W, Wagner JA, Granstein RD. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol. 2006;126:1017-1027.
39. Griesmacher A, Weigel G, David M, Horvath G, Mueller MM. Functional implications of cAMP and Ca2+ on prostaglandin I2 and thromboxane A2 synthesis by human endothelial cells. Arterioscler Thromb. 1992;12:512-518.
40. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 1995;92:2135-2141.
41. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J. 2002;16:1584-1594.
42. Wen J, Dai Y, Zhang Y, Zhang W, Kellems RE, Xia Y. Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production. J Sex Med. 2011;8:2172-2180.
43. Dietrich MS, Endlich K, Parekh N, Steinhausen M. Interaction between adenosine and angiotensin II in renal microcirculation. Microvasc Res. 1991;41:275-288.
44. Lee DL, Bell TD, Bhupatkar J, Solis G, Welch WJ. Adenosine A1-receptor knockout mice have a decreased blood pressure response to low-dose ANG II infusion. Am J Physiol Regul Integr Comp Physiol. 2012;303:R683-R688.
45. Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol. 1996;270(2 Pt 1):C522-C529.
46. Lennon PF, Taylor CT, Stahl GL, Colgan SP. Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med. 1998;188:1433-1443.
47. Kawamura H, Kawamura T, Kanda Y, Kobayashi T, Abo T. Extracellular ATP-stimulated macrophages produce macrophage inflammatory protein-2 which is important for neutrophil migration. Immunology. 2012;136:448-458.
48. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 2006;314:1792-1795.
49. Suh BC, Kim JS, Namgung U, Ha H, Kim KT. P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol. 2001;166:6754-6763.
50. Kukulski F, Bahrami F, Ben Yebdri F, Lecka J, Martín-Satué M, Lévesque SA, Sévigny J. NTPDase1 controls IL-8 production by human neutrophils. J Immunol. 2011;187:644-653.
51. Martinon F. Detection of immune danger signals by NALP3. J Leukoc Biol. 2008;83:507-511.
52. Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology. 2011;216:1-11.
53. van der Hoeven D, Wan TC, Auchampach JA. Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol. 2008;74:685-696.
54. Szabó C, Scott GS, Virág L, Egnaczyk G, Salzman AL, Shanley TP, Haskó G. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol. 1998;125:379-387.
55. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood. 2004;104:3986-3992.
56. Haskó G, Pacher P. Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:865-869.
57. Langston HP, Ke Y, Gewirtz AT, Dombrowski KE, Kapp JA. Secretion of IL-2 and IFN-gamma, but not IL-4, by antigen-specific T cells requires extracellular ATP. J Immunol. 2003;170:2962-2970.
58. Kusu T, Kayama H, Kinoshita M, et al. Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine. J Immunol. 2013;190:774-783.
59. Killeen ME, Ferris L, Kupetsky EA, Falo L Jr, Mathers AR. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. J Immunol. 2013;190:4324-4336.
60. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, Buer J, Ricordi C, Westendorf AM, Grassi F. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal. 2011;4:ra12.
61. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-1232.
62. Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 2008;111:251-259.
63. Erdmann AA, Gao ZG, Jung U, Foley J, Borenstein T, Jacobson KA, Fowler DH. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood. 2005;105:4707-4714.
64. Csóka B, Himer L, Selmeczy Z, Vizi ES, Pacher P, Ledent C, Deitch EA, Spolarics Z, Németh ZH, Haskó G. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 2008;22:3491-3499.
65. Wilson JM, Kurtz CC, Black SG, Ross WG, Alam MS, Linden J, Ernst PB. The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J Immunol. 2011;186:6746-6752.
66. Yoneyama Y, Suzuki S, Sawa R, Takeuchi T, Kobayashi H, Takei R, Kiyokawa Y, Otsubo Y, Hayashi Z, Araki T. Changes in plasma adenosine concentrations during normal pregnancy. Gynecol Obstet Invest. 2000;50:145-148.
67. Yoneyama Y, Sawa R, Suzuki S, Ishino H, Miura A, Kuwabara Y, Kuwajima T, Ito N, Kiyokawa Y, Otsubo Y, Araki T. Regulation of plasma adenosine levels in normal pregnancy. Gynecol Obstet Invest. 2002;53:71-74.
68. Plouzek CA, Leslie KK, Stephens JK, Chou JY. Differential gene expression in the amnion, chorion, and trophoblast of the human placenta. Placenta. 1993;14:277-285.
69. Clapp JF 3rd, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol. 1997;80: 1469-1473.
70. Grindheim G, Estensen ME, Langesaeter E, Rosseland LA, Toska K. Changes in blood pressure during healthy pregnancy: a longitudinal cohort study. J Hypertens. 2012;30:342-350.
71. Mabie WC, DiSessa TG, Crocker LG, Sibai BM, Arheart KL. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 1994;170:849-856.
72. Robson SC, Dunlop W, Moore M, Hunter S. Combined Doppler and echocardiographic measurement of cardiac output: theory and application in pregnancy. Br J Obstet Gynaecol. 1987;94:1014-1027.
73. Escudero C, Sobrevia L. Adenosine plasma levels in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol. 2012;206:e5-e6; author reply e6.
74. Leonard F, Devaux Y, Vausort M, Ernens I, Rolland-Turner M, Wagner DR. Adenosine modifies the balance between membrane and soluble forms of Flt-1. J Leukoc Biol. 2011;90:199-204.
75. Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol Biol Cell. 2007;18:14-23.
76. Blackburn MR, Knudsen TB, Kellems RE. Genetically engineered mice demonstrate that adenosine deaminase is essential for early postimplantation development. Development. 1997;124:3089-3097.
77. Roberts VH, Waters LH, Powell T. Purinergic receptor expression and activation in first trimester and term human placenta. Placenta. 2007;28:339-347.
78. Kittel A, Csapó ZS, Csizmadia E, Jackson SW, Robson SC. Co-localization of P2Y1 receptor and NTPDase1/CD39 within caveolae in human placenta. Eur J Histochem. 2004;48:253-259.
79. Nakano H, Shimada A, Imai K, Takahashi T, Hashizume K. ATP-evoked increase in intracellular calcium via the P2Y receptor in proliferating bovine trophoblast cells. Cell Tissue Res. 2003;313:227-236.
80. Clarson LH, Roberts VH, Greenwood SL, Elliott AC. ATP-stimulated Ca(2+)-activated K(+) efflux pathway and differentiation of human placental cytotrophoblast cells. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1077-R1085.
81. Suzuki S, Yoneyama Y, Sawa R, Otsubo Y, Takeuchi T, Araki T. Relation between serum uric acid and plasma adenosine levels in women with preeclampsia. Gynecol Obstet Invest. 2001;51:169-172.
82. Yoneyama Y, Suzuki S, Sawa R, Yoneyama K, Power GG, Araki T. Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with preeclampsia. Obstet Gynecol. 2002;99:641-646.
83. Bolt A, Faas MM, Borghuis T, Wong M, van Pampus MG, Bakker WW. Placental injury by oxidant stress in preeclampsia. Reprod Sci. 2011;18:79.
84. Hutchinson ES, Brownbill P, Jones NW, Abrahams VM, Baker PN, Sibley CP, Crocker IP. Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. Placenta. 2009;30:634-641.
85. Yoneyama Y, Sawa R, Suzuki S, Otsubo Y, Miura A, Kuwabara Y, Ishino H, Kiyokawa Y, Doi D, Yoneyama K, Kobayashi H, Araki T. Serum adenosine deaminase activity in women with pre-eclampsia. Gynecol Obstet Invest. 2002;54:164-167.
86. Faas MM, van der Schaaf G, Borghuis T, Jongman RM, van Pampus MG, de Vos P, van Goor H, Bakker WW. Extracellular ATP induces albuminuria in pregnant rats. Nephrol Dial Transplant. 2010;25:2468-2478.
87. Blume C, Felix A, Shushakova N, Gueler F, Falk CS, Haller H, Schrader J. Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury. PLoS One. 2012;7:e37100.
88. Koszalka P, Ozüyaman B, Huo Y, et al. Targeted disruption of cd73/ecto- 5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res. 2004;95:814-821.
89. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med. 2004;200:1395-1405.
90. McRae JL, Russell PA, Chia JS, Dwyer KM. Overexpression of CD39 protects in a mouse model of preeclampsia. Nephrology (Carlton). 2013;18:351-355.
91. Bakker WW, Henning RH, van Son WJ, van Pampus MG, Aarnoudse JG, Niezen-Koning KE, Borghuis T, Jongman RM, van Goor H, Poelstra K, Navis G, Faas MM. Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro. Hypertension. 2009;53:959-964.
92. Bakker WW, Spaans F, el Bakkali L, Borghuis T, van Goor H, van Dijk E, Buijnink J, Faas MM. Plasma hemopexin as a potential regulator of vascular responsiveness to angiotensin II. Reprod Sci. 2013;20:234-237.
93. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63:534-543.
94. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep. 2006;58(Suppl):69-74.
95. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol. 2012;93:75-81.
96. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013;94:247-257.
97. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004;44:72-77.
98. Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schröder W, Kaufmann P, Rath W. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta. 1999;20:229-233.
99. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide. 2000;4:441-458.
100. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183:7023-7030.
101. Roberts VH, Webster RP, Brockman DE, Pitzer BA, Myatt L. Post-Translational Modifications of the P2X(4) purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta. 2007;28:270-277.
102. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80-86.
103. Faas MM, Schuiling GA, Baller JF, Bakker WW. Glomerular inflammation in pregnant rats after infusion of low dose endotoxin. An immunohistological study in experimental pre-eclampsia. Am J Pathol. 1995;147:1510-1518.
104. Faas MM, Bakker WW, Baller JF, Schuiling GA. Pregnancy enhances the sensitivity of glomerular ecto-adenosine triphosphate-diphosphohydrolase to products of activated polymorphonuclear leukocytes. Am J Obstet Gynecol. 1999;180(1 Pt 1):112-113.